The lockdown measures introduced by the government in a bid to stop the spread of COVID-19 meant that Peruvians were forced to remain at home from March to May 2020. This therefore limited demand for many dermatological products, with the spread of fungal infections limited and less people exposed to UV rays and other environmental factors which could damage their skin.
ABL Pharma Peru will continue to lead dermatologicals in Peru in 2020 with its Hipoglós and Nistaglos brands in nappy (diaper) rash treatments. Hipoglós is presented in ointment, pomade and spray formats.
In topical antifungals, generics are very important and continue to see increasing value growth due to their affordable prices in comparison with recognised brands. The demand for lower cost products is likely to rise in 2020, as more consumers face reduced disposable incomes and financial difficulties as a result of the COVID-19 crisis.
Consumes are increasingly expected to seek out skin care products with natural ingredients into the forecast period, as they look for products that not only protect them but also help them to look better. This trend towards products with a beauty positioning will encourage more brands to target their products and engage with the consumer base in order to latch onto this trend.
In coming years, there is expected to be a considerable increase in temperature in the warm months, which will bring with it a proliferation of insects and arachnids. This can lead to people getting bitten more often than usual, thereby necessitating an increase in the consumption of pills and creams against infections and bites.
Big companies are expected to continue investing in the marketing of their brands on television and radio, in magazines and on social media. This is not only to support their brands, but also to promote prevention of skin damage and to inform the public about treatments that did not previously have any publicity, such as haemorrhoid treatments or vaginal issues.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Peru with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Peru, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page